Keyphrases
Reimbursement
100%
Oncology
100%
Antineoplastic Agents
100%
Medicare Modernization Act
100%
Medicare Payment Reform
100%
Payment Design
100%
Implications for Future
100%
Physician Office
80%
Practice Patterns
40%
Stage IV Disease
40%
Fluorouracil
40%
Marginal Probability
40%
Bevacizumab
20%
New Drugs
20%
SEER-Medicare
20%
Colon Cancer
20%
Medicare Data
20%
Patient Characteristics
20%
Cetuximab
20%
Natural Experiment
20%
Office Setting
20%
Oxaliplatin
20%
Policy Impact
20%
Outpatient Setting
20%
New Agents
20%
Colon Cancer Patients
20%
Difference Analysis
20%
Multivariate Logistic Regression Model
20%
Cancer Characteristics
20%
Hospital Outpatient Clinics
20%
Outpatient Department
20%
Approved Drugs
20%
Nursing and Health Professions
Medicare
100%
Anticarcinogen
100%
Reimbursement
71%
Health Care Facility
57%
Outpatient Department
28%
Malignant Neoplasm
28%
Colon Carcinoma
28%
Disease
28%
Fluorouracil
28%
Outpatient
14%
Hospital Outpatient
14%
Logistic Regression Analysis
14%
Bevacizumab
14%
Oxaliplatin
14%
Cetuximab
14%
Medicine and Dentistry
Oncology
100%
Medicare
100%
Anticarcinogen
100%
Malignant Neoplasm
28%
Disease
28%
Outpatient
28%
Fluorouracil
28%
Colon Carcinoma
28%
Logistic Regression Analysis
14%
Hospital Outpatient
14%
Oxaliplatin
14%
Bevacizumab
14%
Cetuximab
14%
Agricultural and Biological Sciences
Colon
100%
Bevacizumab
50%
Cetuximab
50%